1-20 of 153
Francisco J. Hernandez-Ilizaliturri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Patients with Prior cBTKi: Safety and Efficacy Including High-Risk Subgroup Analyses from the Phase 1/2 BRUIN Study

Jonathon B. Cohen, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Y. Cheah, Toby A. Eyre, Chaitra S Ujjani, Youngil Koh, Won Seog Kim, Sunita D. Nasta, Ian W. Flinn, Benoit Tessoulin, Shuo Ma, Alvaro J. Alencar, David Lewis, Jennifer A. Woyach, Kami J. Maddocks, Krish Patel, Yucai Wang, Joanna M. Rhodes, Constantine S. Tam, John F. Seymour, Hirokazu Nagai, Julie M. Vose, Bita Fakhri, Marc S. Hoffmann, Francisco J. Hernandez-Ilizaliturri, Andrew D. Zelenetz, Anita Kumar, Talha Munir, Donald E. Tsai, Minna Balbas, Bin Liu, Amy S. Ruppert, Bastien Nguyen, Lindsey E. Roeker, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 981.
https://doi.org/10.1182/blood-2023-181627
Published: 2023
Journal Articles

Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy

Dorothy C Pan, Showkat Hamid, Megan Herr, Kristopher Attwood, Philip L. McCarthy, Maureen Ross, Grant Schofield, Matthew J Cortese, Dominick Lamonica, Jerry Thwin Wong, Kai Fu, Peter Maslak, Marco Davila, Renier Brentjens, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 7376.
https://doi.org/10.1182/blood-2023-187631
Published: 2023
Journal Articles

Novel Drug to Target HK2 Overcomes Therapeutic Resistance in Preclinical B-Cell Lymphoma Models

Juan Gu, Cory Mavis, Jessica C Wang, Kevin Bowman, Taylor K Mandeville, Ahmet E Tatar, Zepnep Benekli, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 5793.
https://doi.org/10.1182/blood-2023-185189
Published: 2023
Journal Articles

Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy

Sanjal H. Desai, Nuttavut Sumransub, Rich Evans, Marcus P Watkins, Reem Karmali, Gaurav Goyal, Mitchell E. Hughes, Arushi Khurana, Francisco J. Hernandez-Ilizaliturri, Joanna Zurko, Ayesha Hassan, Haris Hatic, Imran A. Nizamuddin, Andrew M Evens, Andrea Carolina Anampa-Guzmán, Yi Lin, Iris Isufi, Mehdi Hamadani, Saurabh A Rajguru, Naveena Lall, Aung M. Tun, Brian T. Hill, Deborah M. Stephens, Paolo F. Caimi, Daniel A. Ermann, Brad S. Kahl, Daniel J. Landsburg, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 308.
https://doi.org/10.1182/blood-2023-183001
Published: 2023
Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3087.
https://doi.org/10.1182/blood-2023-173943
Published: 2023
Journal Articles

Treatment Selection and Clinical Outcomes in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) - a Single Center Analysis

Muhammad Junaid Tariq, Andrea Carolina Anampa-Guzmán, Malak Alharbi, Khalid Shalaby, Riya Patel, Showkat Hamid, Anthony George, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri, Matthew J Cortese
Journal: Blood
Blood (2023) 142 (Supplement 1): 4421.
https://doi.org/10.1182/blood-2023-181306
Published: 2023
Journal Articles

Antigen-Specific T-Cell Repertoire Responses Following COVID-19 Vaccination Are Intact in Majority of Patients with B-Cell Lymphoid Malignancies on Active Therapy

Shipra Goel, Elizabeth A. Griffiths, Brahm Segal, Michael Nemeth, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri, Barbara Banbury, Erika Schumacher, Pallawi Torka, Paola Ghione
Journal: Blood
Blood (2023) 142 (Supplement 1): 5714.
https://doi.org/10.1182/blood-2023-190914
Published: 2023
Journal Articles

Venetoclax Pre-Treatment of CLL/SLL Patients Enhances Autologous CAR T-Cells Efficacy

Matthew J Cortese, Cory Mavis, Taylor K Mandeville, Juan Gu, Kevin Bowman, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6518.
https://doi.org/10.1182/blood-2023-189733
Published: 2023
Journal Articles

Germinal Center B-Cell-like (GCB) Phenotype Predicts Improved Outcomes in Central Nervous System Diffuse Large B-Cell Lymphoma Patients Receiving Stereotactic Radiosurgery (SRS)

Farhan Azad, Fatemeh Fekrmandi, Mody Amin, Victor Goulenko, Katy Wang, Kris Attwood, Dheerendra Prasad, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6294.
https://doi.org/10.1182/blood-2023-181222
Published: 2023
Journal Articles

Compatibility of Venetoclax and OPN51107 in Treatment of Mantle Cell Lymphoma

Kevin Bowman, Cory Mavis, Juan Gu, Taylor K Mandeville, Jessica C Wang, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6102.
https://doi.org/10.1182/blood-2023-189739
Published: 2023
Journal Articles

Mitochondrial Reprogramming By Bcl-2 Inhibitor Venetoclax Enhances αCD19 CAR-T Cell Fitness and Anti-Tumor Efficacy

Taylor K Mandeville, Cory Mavis, Juan Gu, Kevin Bowman, Scott Olejniczak, Prasenjit Dey, Gyorgy Paragh, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6845.
https://doi.org/10.1182/blood-2023-191051
Published: 2023
Journal Articles

Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Versus Standard of Care (SOC) with Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Randomized Phase 3 Transform Study

Manali Kamdar, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim G.N.J. Mutsaers, Francisco J. Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, David G. Maloney, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Lara Stepan, Ken Ogasawara, Timothy Mack, Jeremy S. Abramson
Journal: Blood
Blood (2021) 138 (Supplement 1): 91.
https://doi.org/10.1182/blood-2021-147913
Published: 2021
Journal Articles

A Large Multicenter Real-World Evidence (RWE) Analysis of Autoimmune (AI) Diseases and Lymphoma: Histologic Associations, Disease Characteristics, Survival, and Prognostication

Jordan Carter, Adam J. Olszewski, Tatyana A. Feldman, Reem Karmali, Jean L. Koff, Sabarish Ayyappan, Matthew A. Lunning, Shazia Nakohda, Nadia Khan, Aryeh Pelcovits, Jason Lofters, Timothy Seijung Oh, Colin Burke O'Leary, Kittika Poonsombudlert, Carman Tong, Elaine Kuhn, Mingen Liu, Andrea Anampa-Guzman, Megha Shalavadi, Colin Thomas, Melissa Kives, Ning C. Dong, Alexander Hershey, Neil Palmisiano, Alexey V. Danilov, Francisco J. Hernandez-Ilizaliturri, Stefan K. Barta, Frederick Lansigan, Kerry J. Savage, Andrew M. Evens
Journal: Blood
Blood (2021) 138 (Supplement 1): 50.
https://doi.org/10.1182/blood-2021-149728
Published: 2021
Journal Articles

Evaluating the Role of Baseline Geriatric Assessment in Predicting Quality of Life in Older Adults with Non-Hodgkin Lymphoma on Oral Targeted Therapies

Othman Salim Akhtar, Chong Wang, Kristopher Attwood, Desi Carozza, Elizabeth R. Gage-Bouchard, Tunazzina Kaijar, Paola Ghione, Francisco J. Hernandez-Ilizaliturri, Tanya M. Wildes, Pallawi Torka
Journal: Blood
Blood (2021) 138 (Supplement 1): 4094.
https://doi.org/10.1182/blood-2021-149934
Published: 2021
Journal Articles

Age, Sex and Self-Reported Race Differences in Immune Profiles of Hematologic Malignancy Patients

Megan M. Herr, Paul K. Wallace, Yali Zhang, George L. Chen, Sophia R. Balderman, Maureen Ross, Christine Ho, Jens Hillengass, Eunice S. Wang, Amanda Przespolewski, Elizabeth A. Griffiths, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Paola Ghione, Philip L. McCarthy, Theresa E. Hahn
Journal: Blood
Blood (2021) 138 (Supplement 1): 4066.
https://doi.org/10.1182/blood-2021-150954
Published: 2021
Journal Articles

Soluble ICAM-1 As Effective Serologic Marker to Predict Clinical Outcome for Early -Stage I/II Nasal Natural Killer /T-Cell Lymphoma

Juan J Gu, Paola Ghione, Shiyu Jiang, Cory Mavis, Francisco J. Hernandez-Ilizaliturri, Dongmei Ji, Junning Cao, Xiaonan Hong, Xuejun Ma, Qunling Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4542.
https://doi.org/10.1182/blood-2021-149229
Published: 2021
Journal Articles

A Phase I Trial of Nedd8-Activating Enzyme (NAE) Inhibitor, Pevonedistat (PEVO) in Combination with Ibrutinib in Patients with Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL)

Pallawi Torka, Swetha Kambhampati, Alexandra Muir, Kirsten Orand, Lynne Smith, Alex F. Herrera, Lionel Lewis, Francisco J. Hernandez-Ilizaliturri, Lu Chen, Alexey V. Danilov
Journal: Blood
Blood (2021) 138 (Supplement 1): 2433.
https://doi.org/10.1182/blood-2021-146345
Published: 2021
Journal Articles

Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

Brian T. Hill, Caroline J Roth, Rachel Kositsky, Tushar Dave, Cassandra Love, Matthew McKinney, Ahmed Galal, Jadee L Neff, Agrima Mian, Ellen Kendall, Sarah L. Ondrejka, Matthew Chiaramonte, Govind Bhagat, Kenneth Ofori, Ran Reshef, Alexandra E. Kovach, Tarsheen Sethi, Emily F Mason, Shakthi Bhaskar, Olalekan O. Oluwole, Christopher Pallas, Nilanjan Ghosh, Robert Ferdman, George L. Chen, Francisco J. Hernandez-Ilizaliturri, Joanna C. Zurko, Ashley Cunningham, Nirav N. Shah, Boyu Hu, Deborah M. Stephens, Monalisa Ghosh, Neil Bailey, Krish Patel, John M. Pagel, Kavya Kannamma Kannan, Eric D. Hsi, Rakhee Vaidya, Andrew Ip, Andre H. Goy, Swetha Kambhampati, Robert S. Ohgami, Charalambos Andreadis, Elizabeth Thacker, Chrissie Rozzi, Clay Parker, Lanie Happ, Sandeep S. Dave
Journal: Blood
Blood (2021) 138 (Supplement 1): 165.
https://doi.org/10.1182/blood-2021-145764
Published: 2021
Journal Articles

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

Yun Choi, Jessica Caro, Xiaochun Li, Arshed Al-Obeidi, Sharyn Lynn Kurtz, Austin I. Kim, Julie E. Chang, Adam J. Olszewski, Adam Zayac, Andrew Matthews, Stefan K. Barta, Suchitra Sundaram, Francisco J. Hernandez-Ilizaliturri, Lori A. Leslie, Paolo Caimi, Jordan Carter, Kevin A. David, Andrew M. Evens, Myung Sun Kim, Sarah J. Nagle, Judith Goldberg, Catherine S. Diefenbach
Journal: Blood
Blood (2021) 138 (Supplement 1): 184.
https://doi.org/10.1182/blood-2021-146398
Published: 2021
Journal Articles

Contribution of Bcl-2 Inhibitor Venetoclax Toward Anti-CD19 CAR T Cell Efficacy in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Taylor K Mandeville, Cory Mavis, Juan Gu, Scott Olejniczak, Gyorgy Paragh, Prasenjit Dey, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2021) 138 (Supplement 1): 1719.
https://doi.org/10.1182/blood-2021-154128
Published: 2021